Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare · Drug Manufacturers - General
Bristol-Myers Squibb Company is a Healthcare company with a market capitalization of $117.46B, a trailing P/E ratio of 16.1, and a dividend yield of 4.51%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | April 30, 2026 | $1.31 | $1.15 | +13.9% |
| Q4 2025 | February 5, 2026 | $0.53 | $0.98 | -45.9% |
| Q3 2025 | October 30, 2025 | $1.63 | $1.52 | +7.2% |
| Q2 2025 | July 31, 2025 | $1.46 | $1.10 | +32.7% |
| Q1 2025 | April 24, 2025 | $1.80 | $1.50 | +20.0% |
| Q4 2024 | February 6, 2025 | $1.67 | $1.47 | +13.6% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Bristol-Myers Squibb Company's market cap?
As of June 29, 2026, Bristol-Myers Squibb Company (BMY) has a market capitalization of $117.46B.
What is Bristol-Myers Squibb Company's P/E ratio?
Bristol-Myers Squibb Company trades at a trailing price-to-earnings (P/E) ratio of 16.1. Its forward P/E is 8.8.
Does Bristol-Myers Squibb Company pay a dividend?
Yes — Bristol-Myers Squibb Company pays a dividend yielding 4.51%, an annual payout of $2.50 per share.
What sector is BMY in?
Bristol-Myers Squibb Company is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was Bristol-Myers Squibb Company's revenue?
In its latest reported fiscal year (ending December 31, 2025), Bristol-Myers Squibb Company reported revenue of $48.19B and net income of $7.05B.
Ask your own questions about BMY
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.